Geron Corporation, a Bay Area biotech company that's ramping up sales of its first commercial drug, announced on Thursday ...

BioGX President and chief operating officer Shahin Iqbal has nearly 30 years of experience in molecular biology and research.

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could ...

BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry ...

2025 has been the best year for biotechs being acquired by pharma companies since 2019, with nearly $240 billion worth of ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Chai Discovery, an OpenAI-supported biotech startup, has raised $130 million in a Series B round, reaching a valuation of ...

Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...

Biotech hot picks highlight stocks focused on lung disease, neurological disorders and rare conditions, with growth driven by ...

The biotech’s lead asset, AVD-104, failed to beat Astellas’ Izervay at slowing the rate of retina lesion growth, the primary ...

Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...

Analysts might anticipate a good upside ahead for CSL shares, but I think this ASX biotech stock is a much better buy.